Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:03 14/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 85.27 USD | -1.30% |
|
-1.40% | +0.02% |
| Market Cap | 49.15B 43.91B 40.92B 37.1B 69.82B 4,665B 70.37B 490B 192B 2,426B 185B 181B 7,786B | P/E 2026 * |
34.3x | P/E 2027 * | 25.7x |
|---|---|---|---|---|---|
| Enterprise Value | 45.52B 40.66B 37.9B 34.36B 64.67B 4,321B 65.17B 454B 178B 2,247B 171B 167B 7,211B | EV / Sales 2026 * |
6.73x | EV / Sales 2027 * | 5.91x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Tradegate
| EWL | Real-time | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -1.30% | ||
| 1 week | -1.40% | ||
| Current month | -1.22% | ||
| 1 month | +1.07% | ||
| 3 months | -7.10% | ||
| 6 months | +9.15% | ||
| Current year | +0.02% |
| 1 week | 82.42 |  | 86.77 |
| 1 month | 82.42 | | 89.7 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.4 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/10/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 14/9/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/9/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -1.40% | +16.89% | +20.47% | 49.15B | |
| +0.12% | +0.98% | +26.39% | +37.32% | 245B | |
| +0.74% | +3.35% | +8.63% | +6.40% | 157B | |
| -1.30% | +4.27% | -3.14% | +54.52% | 149B | |
| -1.21% | +2.65% | -54.39% | -12.54% | 62.77B | |
| +0.73% | +4.86% | -15.64% | -15.99% | 49.74B | |
| +0.16% | +1.34% | +24.14% | +55.28% | 48.38B | |
| +1.95% | +6.40% | +5.43% | +39.57% | 48.84B | |
| -0.68% | -1.66% | +27.60% | +69.89% | 42.17B | |
| -1.99% | -0.86% | +185.36% | +110.03% | 40.95B | |
| Average | -0.28% | +1.17% | +22.13% | +36.50% | 89.29B | |
| Weighted average by Cap. | -0.18% | +1.16% | +15.88% | +33.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.04B 5.63B 5.11B 9.61B 642B 9.68B 67.46B 26.41B 334B 25.4B 24.84B 1,071B | 7.43B 6.64B 6.19B 5.61B 10.56B 706B 10.64B 74.14B 29.03B 367B 27.92B 27.3B 1,178B |
| Net income | 1.44B 1.28B 1.19B 1.08B 2.04B 136B 2.05B 14.31B 5.6B 70.85B 5.39B 5.27B 227B | 1.9B 1.7B 1.58B 1.43B 2.7B 180B 2.72B 18.93B 7.41B 93.68B 7.13B 6.97B 301B |
| Net Debt | -3.63B -3.24B -3.02B -2.74B -5.16B -345B -5.2B -36.22B -14.18B -179B -13.64B -13.34B -575B | -5.19B -4.64B -4.33B -3.92B -7.38B -493B -7.44B -51.81B -20.28B -256B -19.51B -19.08B -823B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/10/26 | US$85.27 | -1.30% | 3,643,041 |
| 12/10/26 | US$86.39 | +1.38% | 3,324,390 |
| 09/10/26 | US$85.21 | +1.15% | 3,890,502 |
| 08/10/26 | US$84.24 | -1.80% | 6,522,221 |
| 07/10/26 | US$85.78 | -0.81% | 3,508,088 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
